We provide actionable answers from pre-clinical to post-launch. What can Norstella help you with? https://ow.ly/acO550PQWIE #Pipeline2Patient #Answers4Pharma #Pharma Citeline, Evaluate Ltd, MMIT (Managed Markets Insight & Technology), Panalgo, The Dedham Group
Norstella
Information Services
Yardley, PA 45,011 followers
We're on a mission to improve patient access to therapy.
About us
Norstella is a group of prominent pharmaceutical solutions providers – Citeline, Evaluate, MMIT, Panalgo, The Dedham Group – that help clients navigate complexities at each step of the drug development life cycle, from pipeline to patient.
- Website
-
http://www.norstella.com
External link for Norstella
- Industry
- Information Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Yardley, PA
- Type
- Privately Held
Locations
-
Primary
Yardley, PA 19067, US
Employees at Norstella
Updates
-
Norstella is integrating artificial intelligence into our industry-leading data and advisory services to revolutionize drug development and patient care decision-making. https://ow.ly/CIN950SxnQX This integration aims to help biopharma professionals better understand their challenges, anticipate scenarios, and make optimal decisions. To learn more, download the ebook.
-
-
Norstella reposted this
Balancing precision and passion, we push beyond limits to save lives. Discover how Citeline is redefining clinical excellence. https://ow.ly/5WeI50SNbVT
-
The US FDA recently released a diversity-focused draft guidance entitled "Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies." https://ow.ly/53mU50SNn62 Lya Rebelo, Commercial Enablement Manager at Citeline, discusses the future impact of this long-awaited guidance, how it differs from previous FDA diversity guidance, and what Norstella is doing as a life sciences partner to facilitate more diverse clinical development. Click the link in this post to read the full article.
-
-
Norstella reposted this
🏊♂️ Beyond Data, Beyond Limits 🏊♀️ In the race to save lives, every second counts. At Citeline, we push the boundaries to bring clinical trials to the finish line faster. Discover how we go beyond data to make a difference. https://ow.ly/Cb9w50SMnwr
-
Norstella reposted this
📢 Register now for our upcoming #webinar: https://ow.ly/xJ8H50SKSO2 Get to know your webinar hosts: ⭐ Daniel Chancellor has over a decade of experience as an analyst in the biopharma industry, spanning roles in drug discovery, market analysis, competitive intelligence, and strategic consulting. He now develops and leads Thought Leadership across Norstella, producing materials that support clients across a range of hot topics in the biopharma industry. ⭐ David James - In his 25+ years of experience combining a deep knowledge of forecasting methodologies and process, with a passion for innovation, David has consistently been an early adopter of technological advances that result in the delivery of real, tangible value for clients. ⭐ Stefano Driussi - A seasoned software engineer boasting over two decades of industry experience, Stefano is currently focused on integrating AI and machine learning technologies into pharmaceutical forecasting, significantly transforming data interpretation in the industry.
-
Norstella reposted this
The world is watching athletes strive to achieve the impossible. It's the same thing our industry does every day. It's in our nature to try to beat the odds. Data charts the course, but our insights propel us beyond what's possible. Redefine what's possible with Citeline.
-
Our mission is to help patients access life-saving therapies by transforming the drug development journey. Download the "Putting the patient first" report from our leadership roundtable: https://ow.ly/CCaH50SlZvv
-
⭐️ Employee Spotlight Series: April Constable ⭐️ https://ow.ly/hfeR50SFCmu Meet April Constable, Norstella’s visionary Director of communications. With strategic finesse, she keeps our global team informed, engaged, and aligned. Outside work, she enjoys walking the Canary Wharf area of London with her French bulldog, Pig, and is passionate about Pilates. Learn more about April by clicking the link in this post for the full interview. #Pipeline2Patient #FollowNorstella #Norstella
-
-
The likelihood of approval for new Phase I drugs is now just 6.7%. What can drug developers do? In this blog post, Norstella's Daniel Chancellor provides suggestions and an alternative approach to being more risk-averse: https://ow.ly/YnBA50RIPXr.